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INTRODUCTION
Introduction of drugs of the main pharmaco-
therapeutic groups that are proved to be effective, 
safe and of high quality into medical practice re-
mains one of the vital tasks of pharmacy.
Potassium 2,4-dichlorobenzoate under the con-
ditional name Analben has been synthesized by the 
researchers of the National University of Pharmacy.
ABSTRACT
PURPOSE: Analben has been created by the researchers of the National University of Pharmacy and rec-
ommended in the solid dosage form as a promising non-narcotic analgesic and anti-inflammatory drug. The 
aim of the work is to develop physico-chemical and chemical methods of identification and quantitative de-
termination of the active pharmaceutical ingredient in Analben tablets.
MATERIALS AND METHODS: As the object of research a pilot batch of tablets “Analben, 1 mg” pro-
duced by the pharmaceutical firm “Neopharm” together with the company “Zdorovie” was selected. Ana-
lytical studies were performed by the methods of spectrophotometry, thin-layer chromatography and chem-
ical reactions.
RESULTS AND CONCLUSIONS: As the result of the work performed, the spectral characteristics of the 
analben substance in various solvents have been studied, the optimal conditions for determining related im-
purities have been selected using the method of thin-layer chromatography. The spectrophotometric meth-
od for quantitative determination of Analben in the tablets under study has been developed; the solvent, 
concentration and wavelength have been chosen. The validation characteristics of the quantitative determi-
nation method have been studied and it has been determined that linearity is observed in the range of con-
centrations from 0.16 µg/ml to 0.24 µg/ml (±20%), the systematic error of the method (0.33%) is practical-
ly insignificant, the relative confidence interval for the value Z (0.62%) is less than the critical value for con-
vergence of results (1.66%).
Keywords: non-narcotic analgesic, anti-inflammatory drug, Analben, identification, quantitative deter-
mination, tablets
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COOK
ClCl
In the fundamental pharmacological research 
it exhibited anti-inflammatory, analgesic, antipyret-
ic, hepatoprotective and antioxidant properties. It 
has been also found that the compound under study 
does not reveal ulcerogenic and hepatotoxic action 
(3,11,12). These are preconditions for creating a fin-
ished dosage form with the diversified range of the 
pharmacological activity on the basis of the analben 
substance (6,9,10).
Tablets containing analben as an active phar-
maceutical ingredient are allowed for clinical trials 
as a non-narcotic analgesic and anti-inflammatory 
drug. To use the drug in medical practice it is neces-
sary to standardize it. Standardization has been per-
formed according to the requirements of the State 
Pharmacopeia of Ukraine (SPhU) (8).
MATERIAL AND METHODS
A pilot batch of tablets “Analben, 1 mg” pro-
duced by the pharmaceutical firm “Neopharm” to-
gether with the company “Zdorovie” was analyzed. 
During the research the chromatographically pure 
sample of the analben substance was used.
The analytical equipment was Evolution 60S 
(USA) spectrophotometer; AXIS ANG200 balanc-
es (Poland). Reagents (Ethanol (96 per cent); Hydro-
chloric acid; 0,1 M Sodium hydroxide; 0,1 M Hy-
drochloric acid; 0,1 M Potassium hydroxide, alco-
holic; 150 g/l solution of tartaric acid R; 200 g/l so-
lution of sodium cobaltinitrite R), measuring glass-
ware of class A and excipients (lactose monohydrate 
(Pharmatos e®200) s. 10681184 “FrieslandCampan-
ia-DMV B.V.” Netherlands, calcium stearate s. 12, 
EGH.E.Pharm.6.0., starch maize s. E3208, “Roquette 
Freres” France, povidone (Plasdone K-17 polymer), s. 
830811 Ashland, USA) meet the requirements of the 
State Pharmacopoeia of Ukraine (SPhU) (7) which 
are harmonized with the European ones (2).
Materials (filter paper blue dot TC 2642-001-




А. The  ultraviolet spectrum of  absorption of 
the test solution prepared for quantitative determi-
nation in the range from 260  nm to 300 nm should 
have the maxima  at the  wavelengths of 273 nm and 
281 nm, and the shoulder at 288 nm (absorption 
spectrophotometry) (2,7).
В. On  the  chromatogram of the  test solution 
(а) obtained when determining related impurities 
the  principal spot must be detected at the level of the 
principal spot on  the  chromatogram of the reference 
solution (а) and correspond to it by size  and  color-
ation (Fig. 4).
С. Shake 0.5 g of the triturated tablets with 5 
ml of water for 3 min and filter through a paper filter 
(blue dot, fine-pored, highly dense, very slow rate of 
filtration, wet strength). To the filtrate obtained add 
0.5 ml of hydrochloric acid; a white crystalline pre-
cipitate is formed.
D. Shake 1.0 g of the triturated tablets with 10 
ml of water for 3 min  at 20±5°C and filter through a 
paper filter (blue dot, fine-pored, highly dense, very 
slow rate of filtration, wet strength). Divide the fil-
trate into two portions. To the first portion of the 
filtrate add 2 ml of the freshly prepared solution of 
200g/l of sodium cobaltinitrite; a yellow or orange 
precipitate is formed.
Е. To another portion of the filtrate add 2 ml of 
150 g/l of tartaric acid solution and leave off; a white 
crystalline precipitate is formed.
Tests
Related impurities (thin-layer chromatography). 
Test solution. To the accurately weighed tablet 
powder, which is equivalent to 5 mg of analben add 
5 ml of 96% ethyl alcohol, shake for 3 min, dilute the 
solution to the volume of 10 ml with the same sol-
vent, mix and filter. 
Reference solution (а). Dissolve 5 mg of analben 
reference standard (RS) in 5 ml of 96% ethyl alcohol 
and dilute the solution to the volume of 10 ml with 
the same solvent. Prepare the solution immediately 
prior to use.
Plate: TLC plates (10 cm x 20 cm) with the layer 
of silica gel F
254
 Р.
Mobile phase: 96% ethyl alcohol.
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Application: 5 mcl.
Development: over a path of 15 cm.
Drying: in the air for 15 min.
Detection: examine in ultraviolet light at 365 
nm.
Chromatographic system suitability: 
 ❖ R
f 
of the principal spot on the chromatogram of 
the test solution: from 0.55 to 0.65;
 ❖ on the chromatogram of the reference solution 
(a) two clearly separated spots must be detected. 
Limit: - any related impurities: on the chro-
matogram of the test solution (а) any spot, excluding 
the principal one, must not be more intense than the 
spot on the chromatogram of the reference solution 
(а) (0.5%) (Fig. 4). 
Assay (absorption spectrophotometry).
Test solution. Place accurately weighed portion 
of the tablet powder equivalent to 5 mg of analben 
into a 50 ml volumetric flask, add 10 ml of ethyl al-
cohol, shake for 15 min, filter into a 25 ml volumet-
ric flask. Shake twice the precipitate with 5 ml of eth-
yl alcohol and filter through the same filter into the 
same flask. Add 2 ml of 0.1 M solution of hydrochlo-
ric acid, dilute the solution to the volume with ethyl 
alcohol and mix. 
Reference solution. Dissolve 50 mg of analben 
RS in ethyl alcohol and dilute the solution to the vol-
ume of 50.0 ml with the same solvent. To 5.0 ml of 
the solution obtained add 2 ml of 0.1 M solution of 
hydrochloric acid, dilute the solution to the volume 
of 50.0 ml with ethyl alcohol and mix.
Blank solution. Dilute 2 ml of 0.1 M solution of 
hydrochloric acid with ethyl alcohol to 25.0 ml.
The optical density of the test solution and the 
reference solution is measured at the wavelength of 
281 nm with respect to the compensation solution.








K in one tab-
let, in milligrams, equivalent to the average weight of 











To develop the method of identification and 
quantitative determination of analben by absorption 
spectrophotometry we prepared 0.02% solutions of 
analben in water and alcohol, and studied their UV-
spectra in the region from 220 nm to 300 nm (Fig. 1). 
As it is seen from the given spectra, in water the ab-
sorption maxima were observed at the wavelengths 
of 222 nm, 230 nm, 235 nm, 273 nm and 281 nm that 
correspond to absorption of the benzene ring. When 
replacing the solvent to ethyl alcohol the absorption 
maxima were observed at 221 nm, 225 nm, 230 nm, 
235 nm, 275 nm and 284 nm and were similar by 
intensity.
The flattest absorption maxima were observed 
at the wavelengths of 273 nm and 281 nm in water, 
and 275 nm and 284 nm in ethyl alcohol. It was ex-
pedient to study the effect of рН on the character of 
the analben spectrum when adding acid or alkali. 
For this purpose the absorption spectra of analben in 
water and alcohol, as well as with addition of 0.1 M 
solution of hydrochloric acid or 0.1 М solution of so-
dium hydroxide were registered (Fig. 2, 3).
Fig. 1. The UV-spectra of 0.02% solution of analben: 1 – in 
ethyl alcohol; 2 – in water
Fig. 2. The UV-spectra of 0.02% solution of analben: 1 – 
in water with addition of 0.1 M solution of hydrochloric 
acid; 2 – in water; 3 – in water with addition of 0.1 М 
solution of sodium hydroxide
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As seen from the given spectra, when adding 
0.1 М solution of sodium hydroxide or alcoholic so-
lution of potassium hydroxide to the aqueous (Fig. 
2) or alcoholic (Fig. 3) solutions of analben, respec-
tively, the character of the spectra does not change; it 
can testify that the solutions are not hydrolyzed and 
there is no process of hydrolysis suppression. In case 
of addition of 0.1 M solution of hydrochloric acid a 
hypsochromic shift is observed, the intensity of the 
spectrum almost doubles and there is one rather flat 
maximum at the wavelength of 281 nm (Fig. 2) or 
two maxima at the wavelengths of 273 nm and 281 
nm and the shoulder at 288 nm (Fig. 3). 
This is due to the fact that the process of the 
substance transfer into the acidic form occurs and 
the dissociation process of the acid obtained is sup-



































Cl+    
HCl
+ +
Thus, we recommend toperform identification 
of analben in tablets using spectrophotometry in the 
range from 260 nm to 300 nm in alcoholic medium 
with addition of 0.1 M solution of hydrochloric acid 
indicating positions of maxima and the shoulder.
The method of thin-layer chromatography was 
used for identification of the active pharmaceutical 
ingredient in tablets and the test for purity. The re-
search was conducted on “TLC 60F254” plates in al-
cohol. The chromatogram was detected with in the 
ultraviolet light at the wavelength of 365 nm. On the 
chromatogram of the test solution the principal spot 
is observed; by size, coloration and location it corre-
sponds to the principal spot on the chromatogram of 
the reference solution (the analben sample of chro-
matographic grade). R
f
 for analben is approximate-
ly 0.65 (Fig. 4).
To prove analben to be the salt of a weak or-
ganic acid the reaction of interaction with a strong 
mineral acid was carried out. As a result, a precipitate 
of 2,4-dichlorobenzoic acid identified by the melting 
point (160-164оС) was formed. The presence of po-
tassium cation was proven by pharmacopoeias reac-
tions (7). 
Fig. 3. The UV-spectra of 0.02% solution of analben: 1 – 
in alcohol with addition of 0.1 M solution of hydrochloric 
acid; 2 – in alcohol; 3 – in alcohol with addition of 0.5 М 
alcoholic solution of potassium hydroxide
Fig. 4. TLC of analben identification and related 
impurities 
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Quantitative determination of analben in tab-
lets was performed by the method of spectropho-
tometry after extraction of the active substance from 
the tablet mass with the help of ethylic alcohol. 0.1 
M solution of hydrochloric acid was added to in-
crease the intensity of the absorption spectrum, and 
the spectrophotometric study was conducted at the 
wavelength 281 nm. During the spectrophotometric 
method development the effect of excipients on the 
nature of the spectrum was studied 
According to the standardized procedure 
(1,4,5), the following validation characteristics of the 
recommended method for quantitative determina-
tion of analben – robustness, specificity, linearity, 
convergence, accuracy and the range of application 
have been studied.
Robustness was determined by studying stabil-
ity of solutions over time and the effect of рН. It has 
been found that the test solution of analben is sta-
ble for an hour. When studying the influence of рН 
changes on the character of the spectrum different 
amounts of 0.1 M solution of hydrochloric acid were 
added to the same weighed portion of analben and 
the optical density of the solution obtained was mea-
sured at the wavelength of 281 nm. As can be seen 
from the data obtained (Table 1), with increase of the 
acid concentration the optical density does not prac-
tically change, but after addition of 2 ml of 0.1 M so-
lution of hydrochloric acid the more constant values 
are reached, that is why this volume is added to the 
reaction mixture.
To confirm specificity of the method the rela-
tive systematic error introduced by the solvent and 
excipients of tablets was calculated. For this purpose 
the optical density (А
blank
) of the placebo solution and 
the optical density (A
100%
) of the test solution were de-
termined three times with removing the cuvette. The 





indicate the absence of a significant impact on the re-
sults of measurements since the contribution of pla-
cebo in the total absorption of the analytical solution 
is δ
exc
Linearity, convergence, accuracy and the range 
of the method application were studied on the mod-
el mixtures within the range of concentrations from 
80% to 120% in relation to the nominal value. Solu-
tions with the known concentration were obtained 
by diluting the initial model solution. The work-
ing concentration of the test solution and the refer-
ence solution was about 0.20 mg/ml. The linear de-
pendence of the optical density of analben solutions 
from the concentration in the range from 0.16 mcg/
ml to 0.24 mcg/ml (±20%) was found. The results are 
given in the normalized coordinates (Fig. 5).
The calculation of the linear dependence pa-
rameters Y
i i
+a for analben (Table 2) was per-
formed by the least square method (according to the 
data of Table 3); its results were compared with the 
acceptance criteria given in the SPhU (8).
Optical density Amount of 0.1 M solution of hydrochloric acid, ml
0.50 1.00 1.50 2.00 2.50
А 0.572 0.577 0.579 0.576 0.576
Table 1. The effect of рН on the optical density of alcoholic solutions of analben





a 0.9662 1) 1.8595  S
a
 = 1.77;








r 0.9997 ≥ 0.9924 satisfied
Table 2. Statistical characteristics of the linear dependence
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The data of Table 2 testify that all requirements 
to the linear dependence parameters are met, i.e. lin-
earity of the method is confirmed within the range of 
the concentrations selected (80-120%).
The results obtained (Table 3) testify that the 
criteria of the systematic error insignificance are per-
formed. The systematic error of the method (0.33%) 
is practically insignificant, i.e. the method of analy-
sis is characterized by satisfactory correctness with-
in the range of concentrations from 80% to 120% and 
precision (convergence) since the relative confidence 
interval for the value Z (0.62%) is less than the critical 
value for convergence of results (1.66%).
Therefore, the complex physico-chemical and 
chemical investigations conducted allowed to devel-
op the project of methods for quality control on the 
dosage form under research – Analben tablets.
CONCLUSIONS
1. The methods of identification of Analben in 
tablets have been developed by absorption ul-
traviolet spectrophotometry, thin-layer chro-
matography and chemical reactions.
2. The conditions have been selected and the 
method of spectrophotometric quantitative 
determination of Analben in tablets has been 
developed. The validation characteristics of 
the quantitative determination method for 
analben have been studied using the accep-
tance criteria for tolerances of the active in-
Fig. 5. The linear dependence of the optical density 
from the concentration of analben in the normalized 
coordinates
No. of the test 
solution
Introduced in % to 
the concentration of 










Found in % to the 
concentration of the 
reference solution
(Yi=Ai/Ast, %)
Found in % to the in-
troduced Zi=100 
(Yi/Xi)
1 80 0.495 79.71 99.64
2 85 0.527 84.86 99.84
3 90 0.560 90.18 100.20
4 95 0.588 94.69 99.67
5 100 0.620 99.84 99.84
6 105 0.653 105.15 100.15
7 110 0.684 110.14 100.13
8 115 0.711 114.49 99.56
9 120 0.739 119.00 99.17
Mean, Z% 99.80
Relative standard deviation, Sz% 0.33
Relative confidence interval Δas%=t(95%,8) Sz 0.62
Critical value for convergence of results Δas% 2.24
Systematic error δ -0.20
Criterion of the systematic error insignificance 1) δ≤Δas/(g)^0,5=0,72/√9, 2) if it is not 
satisfied 1), then δ≤0.72 0.24
The overall conclusion of the method correct
Table 3. The results of analysis for test solutions and their statistical processing
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gredient content of ±10%, and they confirm 
specificity, linearity, convergence, accuracy 
and the range of the method application.
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